Pivotal Point Tracking Abbott Laboratories (ABT): Medical Technology Giant Shines with Strong Numbers - Glucose Monitoring System FreeStyle Libre as Driver
Reading Time: 1 minute
Abbott Laboratories is a globally leading US medical technology and healthcare company. On July 16, the company exceeded analysts' expectations with its second-quarter results. The adjusted earnings per share amounted to $1.31. The company also shone in terms of revenue, with $12.59 billion, which is about 13% higher than the previous year's figure. The strong growth in the medical technology sector was again the key driver, particularly the glucose monitoring system FreeStyle Libre. Due to robust demand, the EPS forecast for the full year was slightly...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

